BE903701A - Composition aqueuse de cromoglycate de sodium. - Google Patents

Composition aqueuse de cromoglycate de sodium.

Info

Publication number
BE903701A
BE903701A BE0/215905A BE215905A BE903701A BE 903701 A BE903701 A BE 903701A BE 0/215905 A BE0/215905 A BE 0/215905A BE 215905 A BE215905 A BE 215905A BE 903701 A BE903701 A BE 903701A
Authority
BE
Belgium
Prior art keywords
sodium cromoglycate
aqueous composition
formulation
cromoglycate
sodium
Prior art date
Application number
BE0/215905A
Other languages
English (en)
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24706028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE903701(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of BE903701A publication Critical patent/BE903701A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Composition aqueuse de cromoglycate de sodium qui a une viscosité de 2 à 300mPa.s et contient de préférence de l'hydroxypropylméthylcellulose. Procédé de traitement des affections allergiques de l'oeil et du nez au moyen de la composition. Dans une forme de réalisation préférée, l'hydroxypropylméthylcellulose contient 20 à 30 % de radicaux méthoxy et 4 à 12 % de radicaux hydroxypropoxy et a une température de gélification en milieu aqueux entre 45 et 90 degrés C.
BE0/215905A 1984-11-23 1985-11-22 Composition aqueuse de cromoglycate de sodium. BE903701A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67428284A 1984-11-23 1984-11-23

Publications (1)

Publication Number Publication Date
BE903701A true BE903701A (fr) 1986-05-22

Family

ID=24706028

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215905A BE903701A (fr) 1984-11-23 1985-11-22 Composition aqueuse de cromoglycate de sodium.

Country Status (18)

Country Link
EP (1) EP0183457B1 (fr)
JP (1) JPH0639379B2 (fr)
AT (1) ATE71524T1 (fr)
AU (2) AU4999785A (fr)
BE (1) BE903701A (fr)
CA (1) CA1267848A (fr)
CH (1) CH666816A5 (fr)
DE (1) DE3585211D1 (fr)
DK (1) DK541285A (fr)
FR (1) FR2573652B1 (fr)
GB (1) GB2167300B (fr)
GR (1) GR852791B (fr)
IE (1) IE59195B1 (fr)
IL (1) IL77086A0 (fr)
LU (1) LU86172A1 (fr)
NZ (1) NZ214295A (fr)
PT (1) PT81538A (fr)
ZA (1) ZA858914B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317226C (fr) * 1987-05-04 1993-05-04 Phillip E. Pennell Liquide visco-elastique pour chirurgie ophtalmique et methode d'utilisation
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
IL97075A0 (en) * 1990-02-14 1992-03-29 Alcon Lab Inc Topical pharmaceutical composition containing an alkyl saccharide
DE19539532C2 (de) * 1995-10-24 1999-02-25 Mann Gerhard Chem Pharm Fab Ophthalmisches Cromoglicat-Gelpräparat
WO2000042986A2 (fr) * 1999-01-19 2000-07-27 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Liquide lacrymal artificiel en gel
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
JP5364658B2 (ja) * 2000-07-21 2013-12-11 ロート製薬株式会社 点眼剤
WO2005003111A1 (fr) * 2003-07-04 2005-01-13 Astellas Pharma Inc. Agent de prevention ou de traitement de la conjonctivite virale
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
ES2457442T3 (es) * 2009-05-08 2014-04-25 Pari Pharma Gmbh Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
JP2013231185A (ja) * 2013-06-12 2013-11-14 Pfizer Products Inc ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
CN106535889A (zh) 2014-02-10 2017-03-22 帕塔拉制药有限责任公司 用于治疗肺疾病的肥大细胞稳定剂
CA2938994A1 (fr) 2014-02-10 2015-08-13 Patara Pharma, LLC Formulations inhalables de cromolyne de sodium a biodisponibilite amelioree
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
EP3331522A1 (fr) 2015-08-07 2018-06-13 Patara Pharma LLC Méthodes de traitement de troubles liés aux mastocytes par des stabilisateurs de mastocytes
EP3506893A4 (fr) 2016-08-31 2020-01-22 Respivant Sciences GmbH Compositions de cromolyne pour le traitement de la toux chronique due à une fibrose pulmonaire idiopathique
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones
US4268519A (en) * 1979-06-05 1981-05-19 Fisons Limited Method of treating otitis media
JPS5756448A (en) * 1980-09-22 1982-04-05 Mitsui Toatsu Chem Inc Preparation of aromatic isocyanate

Also Published As

Publication number Publication date
AU4999785A (en) 1986-05-29
IE852942L (en) 1986-05-23
IL77086A0 (en) 1986-04-29
GB2167300A (en) 1986-05-29
IE59195B1 (en) 1994-01-26
DK541285A (da) 1986-05-24
EP0183457A3 (en) 1987-04-15
EP0183457A2 (fr) 1986-06-04
CA1267848A (fr) 1990-04-17
GB8528190D0 (en) 1985-12-18
LU86172A1 (fr) 1986-03-24
JPS61143318A (ja) 1986-07-01
NZ214295A (en) 1988-07-28
CH666816A5 (fr) 1988-08-31
GR852791B (fr) 1986-03-21
EP0183457B1 (fr) 1992-01-15
AU4431189A (en) 1990-02-22
FR2573652A1 (fr) 1986-05-30
GB2167300B (en) 1988-11-23
ATE71524T1 (de) 1992-02-15
FR2573652B1 (fr) 1988-09-02
JPH0639379B2 (ja) 1994-05-25
PT81538A (en) 1985-12-01
DE3585211D1 (de) 1992-02-27
ZA858914B (en) 1987-07-29
DK541285D0 (da) 1985-11-22

Similar Documents

Publication Publication Date Title
FR2573652B1 (fr) Composition aqueuse de cromoglycate de sodium
PT89835A (pt) Processo para a preparacao de uma formulacao de relaxina humana
DK486282A (da) Fremgangsmaade til fremstilling af 5- eller 6-hydroxy-2-benzothiazolsulfonamider
PT89520A (pt) Processo para a preparacao de derivados de quinolino e acido naftiridino-carboxilicos substituidos por alquilo na posicao 5 e substituidos por um anel de piperazina ou pirrolidina na posicao 7 e de composicoes farmaceuticas que os contem
SE8403090D0 (sv) Gel for anvendning som glaskroppssubstitut
NO891377D0 (no) Hudfuktningspreparat og fremgangsmaate for fremstilling derav.
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
ATE109001T1 (de) Mittel zur stimulierung der tränensekretion.
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
PT83478B (pt) Processo para a prepracao de novos derivados polioxigenados de labdano e de composicoes farmaceuticas que os contem
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
DE69002697D1 (de) Carboplatinzusammensetzung.
PT93915A (pt) Processo para a preparacao de novos derivados de 4-fenil-metil-1h-indol e de composicoes farmaceuticas que os contem
ATE107852T1 (de) Badezusatz und dessen verwendung.
ES2085833B1 (es) Derivados de carboximetilidencicloheptimidazol y metodo para prepararlos.
SE8404130D0 (sv) New injectable compositions
ATE113040T1 (de) Anwendung von naphthoxazinen.
BR8303239A (pt) Processo para preparar um derivado de organofosfato, processo para preparar um derivado de fenol utilizavel no mesmo, composicao pesticida e aplicacao do derivado citado no inicio
IT8522912A0 (it) Formulazione acquosa di sodio cromo glicato con viscosita' compresa fra 2 e 300 mpa.s e metodo per prepararla
ES540308A0 (es) Un procedimiento de producir un agente promotor de la erec- cion y de la fertilidad
ATE52782T1 (de) Ein-topfverfahren fuer herstellung von 7 betaamino- und 7 beta-acylamino-3-substituierte
SE9302201D0 (sv) Composition for ophthalmic use
JPS5735932A (en) Emulsifier composition

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FISONS P.L.C.

Effective date: 19931130